Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia-Reference-Cited by-同舟云学术

Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia

Published:2019-04-15 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Rashidi Armin,Kaiser Thomas,Shields-Cutler Robin,Graiziger Carolyn,Holtan Shernan G.,Rehman Tauseef Ur,Wasko Justin,Weisdorf Daniel J.,Dunny Gary,Khoruts Alexander^ORCID,Staley Christopher^ORCID

Funder

University of Minnesota Innovation Grant

Funding from Achieving Cures Together Funding from Hubbard Foundation

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-42652-6.pdf

Reference52 articles.

1. Galloway-Peña, J. R. et al. Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients. Genome Med. 9, 21 (2017).

2. Galloway-Peña, J. R. et al. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer 122, 2186–96 (2016).

3. Hakim, H. et al. Gut Microbiome Composition Predicts Infection Risk During Chemotherapy in Children With Acute Lymphoblastic Leukemia. Clin. Infect. Dis., https://doi.org/10.1093/cid/ciy153 (2018).

4. Yu, L. C.-H. et al. Enteric dysbiosis promotes antibiotic-resistant bacterial infection: systemic dissemination of resistant and commensal bacteria through epithelial transcytosis. Am. J. Physiol. Gastrointest. Liver Physiol. 307, G824–35 (2014).

5. Garcia-Vidal, C. et al. Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance. PLoS One 13, e0199531 (2018).

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causal Relationship Between Gut Microbiota and Leukemia: Future Perspectives;Oncology and Therapy;2024-09-01

2. An enterococcal phage-derived enzyme suppresses graft-versus-host disease;Nature;2024-07-10

3. CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasis;Blood;2024-04-18

4. Gut diversity and the resistome as biomarkers of febrile neutropenia outcome in paediatric oncology patients undergoing hematopoietic stem cell transplantation;Scientific Reports;2024-03-06

5. Technology SpotlightThe Role of the Microbiome in Hematology;The Hematologist;2024